Business
Todos Medical Announces Third Quarter 2022 Financial Results
Todos Medical Announces Third Quarter 2022 Financial Results.
About this update from Todos Medical Ltd.
[{"type":"text","content":"\n §  89% increase in Q3/2022 quarterly revenues as compared with Q3/2021 §  Earnings and business update call to be held at 8:30am ET on November 15, 2022  New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced financial results today for the third quarter of 2022, which ended on September 30, 2022. The Company will host a conference call today at 8:30am ET on November 15, 2022. “We achieved key milestones in the third quarter of 2022 to diversify our PCR lab testing revenue and expand the target audience for our dietary supplement business,” said Gerald Commissiong, President & CEO of Todos. “As we move towards the end of the year and prepare for 2023, we believe Todos is well positioned to continue to drive revenue growth across all business verticals and prepare to bring our proprietary product portfolio to market in 2023.” Conference Call DetailsTime: Tuesday, November 15, 2022 at 8:30am ETLink: https://audience.mysequire.com/webinar-view?webinar_id=c823522b-146b-4b30-8243-3e16afc4ac24Optional Dial-In: +1-346-248-7799 Meeting ID: 93308656732 Passcode: 151033 Q3/2022 Corporate Highlights Provista Diagnostics validation and launch of non-COVID PCR testing service and successful pilot launch of pharmacist-integrated testing service Provista Diagnostics, the Company’s CLIA/CAP-certified clinical testing laboratory based in the Atlanta, GA area, successfully completed CLIA validation protocols for a suite of PCR-based diagnostic testing panels and successfully completed a pilot launch of those testing panels into the Dunnellon, FL area medical community. The PCR tests validated include:1.     Urinary Tract Infection (UTI)2.     Respiratory Pathogen Panel (RPP)3.     Gastrointestinal Panel (GIP)4.     Wound Panel (WP)5.     Sexually Transmitted Infection Panel (STIP)6.     MonkeyPox (MP) The testing service, which includes sample pick-up, shipping to the lab, running the PCR test, pharmacist assessment of best likely therapies based on pathogen positivity, and reporting...